Status:
COMPLETED
Understanding Immunity to the COVID-19 Vaccines
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
COVID-19
Immunity
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.
Eligibility Criteria
Inclusion
- Adults who are receiving a COVID-19 vaccine
Exclusion
- Patients with special risks attendant to venipuncture
Key Trial Info
Start Date :
March 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 6 2022
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04664309
Start Date
March 26 2021
End Date
January 6 2022
Last Update
February 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University, Hospital, and Clinics
Stanford, California, United States, 94305